07:00 , Jun 5, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML); myelodysplastic syndrome (MDS) BET bromodomain proteins; myeloid-lymphoid or mixed-lineage leukemia 3 (MLL3) In...
08:00 , Jan 20, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Myeloid/lymphoid or mixed-lineage leukemia 2 (MLL2); MLL3 A genomic study...